# Synthetic drugs (medicinal chemistry): Overview

Source page: https://www.materialinsights.org/technologies/synthetic_drugs/tech-overview/

#### What it does

The job the technology does for people, in a short paragraph

Synthetic drugs are medicines whose active molecule is made by chemical reactions rather than taken from a plant or animal. The approach took off when Bayer's laboratory made pure acetylsalicylic acid in 1897 and registered it as Aspirin in 1899 ^[1]. Most medicines taken today are made this way, and world medicine use is expected to approach 4 trillion daily doses a year by 2030 ^[5].

as of 2026-11-10

#### How it works

The working principle in plain words, step by step

A drug works by fitting a molecule in the body, often a receptor on a cell or an enzyme, and changing what it does ^[4]. The shape and charge of the drug decide how well it fits. Medicinal chemists start from a lead, a compound with some useful effect, and change its structure one piece at a time to make it stronger, safer or longer lasting. Aspirin is an early example: chemists joined salicylic acid, the active part of willow bark, with acetic anhydride to make a new compound ^[1]. Ehrlich's team tested many compounds before number 606 worked against syphilis ^[2]. Once chosen, the molecule is built in a chain of reactions from simpler chemicals, purified, and pressed into tablets or dissolved for injection.

as of 2026-11-10

#### Key figures

The handful of numbers that size it up, each with its unit, year and source

| Figure | Value | Unit | Year | Source |
|---|---|---|---|---|
| World spending on medicines expected by 2030 (more than) | 2.6 | trillion USD | 2030 | ^[5] |
| Expected yearly growth of world medicine spending, low end (range 5 to 8%) | 5 | % | 2026 | ^[5] |
| World medicine use expected by 2030 | 4 | trillion defined daily doses | 2030 | ^[5] |
| Share of facilities making active ingredients for the US market that are in the United States | 28 | % | 2019 | ^[7] |

Estimate · as of 2026-11-10. Rows 1 to 3 are IQVIA forecasts at makers' prices before discounts, covering all medicines, not only synthetic ones, so the item is marked estimate [5]; row 4 is the FDA's count for August 2019 [7].

#### Where it is used

The main places and products the technology is found in

- Painkillers and fever reducers such as aspirin ^[1]
- Medicines against infection, from Salvarsan for syphilis ^[2] to the sulfonamides ^[3]
- Daily medicines for the heart, blood pressure and blood sugar
- Cancer medicines, many of them small molecules made by synthesis
- Medicines for the mind, from sedatives to antidepressants

as of 2026-11-10

#### Scale today

How much of it there is now: units in use, made each year and who uses it

**Users**
: World medicine use is expected to approach 4 trillion defined daily doses a year by 2030 ^[5]

**Unit**
: defined daily doses

**Year**
: 2030

**Note**
: A forecast; a defined daily dose is the standard daily amount of a medicine for an adult, and the count covers all medicines, not only synthetic ones.

as of 2026-11-10

#### Sources

1. [Aspirin (Brands with history)](https://dpma.de/english/our_office/publications/milestones/brandswithhistory/aspirin/index.html) German Patent and Trade Mark Office (DPMA)
2. [Early Solution](https://www.sciencehistory.org/distillations/magazine/early-solution) Science History Institute, Distillations (Gigi Naglak and Rosie Cook), 2012
3. [Gerhard Domagk: Facts](https://www.nobelprize.org/prizes/medicine/1939/domagk/facts/) Nobel Prize Outreach (NobelPrize.org)
4. [John Newport Langley, FRS](https://explore.trin.cam.ac.uk/assets/langley/) Trinity College, Cambridge
5. [Global Medicine Use Trends 2026](https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/the-global-use-of-medicines-outlook-through-2029) IQVIA Institute for Human Data Science, 2026
6. [Safeguarding Pharmaceutical Supply Chains in a Global Economy (testimony of Janet Woodcock)](https://www.fda.gov/news-events/congressional-testimony/safeguarding-pharmaceutical-supply-chains-global-economy-10302019) US Food and Drug Administration, 2019

## Other sections

- [Summary](https://www.materialinsights.org/technologies/synthetic_drugs/index.md)
- [Science](https://www.materialinsights.org/technologies/synthetic_drugs/tech-science/index.md)
- [Evolution](https://www.materialinsights.org/technologies/synthetic_drugs/tech-evolution/index.md)
- [Materials](https://www.materialinsights.org/technologies/synthetic_drugs/tech-materials/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/synthetic_drugs/tech-energy-footprint/index.md)
- [Industries](https://www.materialinsights.org/technologies/synthetic_drugs/tech-industries/index.md)
